361 T cell receptor specific for tumor-restricted Ropporin-1 to treat triple negative breast cancer

• John WM Martens,
• Reno Debets,
• Justine Michaux,
• Michal Bassani-Sternberg,
• Dian Kortleve,
• Sonja Buschow,
• Monique de Beijer,
• Dora Hammerl,
• Mandy Van Brakel,
• Rebecca Wijers,
• Daphne Roelofs,
• Madelon Badoux,
• Mieke A Timmermans,
• Anita C Liao,
• Erik Danen,
• Rachel JM Abbott

Affiliations

John WM Martens

5 Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute/Erasmus University Medical Center, Rotterdam, The Netherlands

Reno Debets

Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands

Justine Michaux

Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland

Michal Bassani-Sternberg

Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland

Dian Kortleve

2Erasmus MC Cancer Institute, Rotterdam, Netherlands

Sonja Buschow

Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands

Monique de Beijer

1Erasmus MC University Medical Center, Rotterdam, Netherlands

Dora Hammerl

1Pan Cancer T, Rotterdam, Netherlands

Mandy Van Brakel

2Erasmus MC Cancer Institute, Rotterdam, Netherlands

Rebecca Wijers

2Erasmus MC Cancer Institute, Rotterdam, Netherlands

Daphne Roelofs

1Pan Cancer T, Rotterdam, Netherlands

Madelon Badoux

1Pan Cancer T, Rotterdam, Netherlands

Mieke A Timmermans

2Erasmus MC Cancer Institute, Rotterdam, Netherlands

Anita C Liao

3Leiden Academic Centre for Drug Research, Leiden, Netherlands

Erik Danen

3Leiden Academic Centre for Drug Research, Leiden, Netherlands

Rachel JM Abbott

1Pan Cancer T, Rotterdam, Netherlands